These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6885203)

  • 1. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (Theolair and Theolair retard) in normals and asthmatics. Part II: Lung function and side effects.
    Utama I; Kreukniet J; Fokkens J; Serra R
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):292-6. PubMed ID: 6885203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (Theolair and Theolair retard) in normals and patients with COLD. Part III: Plasma cyclic AMP.
    Kreukniet J; Utama I; Hamelink ML
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):297-300. PubMed ID: 6309681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (theolair and Theolair retard) in normals and asthmatics. Part I: pharmacokinetics.
    Utama I; Kreukniet J; Meering PG; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):287-91. PubMed ID: 6885202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.
    van der Vet AP; Kreukniet J; Drost RH; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP; Drost RH; Kreukniet J; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous use of rapidly absorbed and sustained release theophylline preparations in children.
    Hein EW; Domson JF; Sheen A; Buffone GJ; Sly RM
    Ann Allergy; 1979 Oct; 43(4):217-9. PubMed ID: 555597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparative trial between two sustained-release theophylline preparations with individual doses in asthmatic in-patients.
    Van der Meer YG; Van Alphen AC; Van Altena R; Van Loenen AC
    Pharm Weekbl Sci; 1982 Dec; 4(6):183-90. PubMed ID: 6760111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of theophyllines in severe chronic obstructive pulmonary disease.
    McNicholas WT; Mulloy E
    Postgrad Med J; 1991; 67 Suppl 4():S30-3. PubMed ID: 1758832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ
    Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis.
    van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):569-73. PubMed ID: 3023243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-acting versus a long-acting preparation of theophylline ('Xantivent') in the treatment of reversible bronchospasm.
    Andrasch R; Schmitz-Schumann M
    Pharmatherapeutica; 1984; 3(10):668-77. PubMed ID: 6463066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V; Nicora M; Beretta A
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effectiveness of delayed-action theophylline preparations].
    Tsoĭ AN; Gavrilenko LN; Bogovskiĭ BP; Semenova LG; Iuldasheva LI
    Klin Med (Mosk); 1990 Sep; 68(9):72-5. PubMed ID: 2290338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prescription of Theostat 300 as a single evening dose].
    Germouty J; Bida C; Moreau L
    Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of protheo on pulmonary function and the change of its plasma concentration in patients with chronic asthmatic bronchitis].
    Li S; Chen Y; Tan P
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):299-300. PubMed ID: 10374457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H
    Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guide to oral theophylline therapy for the treatment of chronic asthma.
    Hendeles L; Weinberger M; Wyatt R
    Am J Dis Child; 1978 Sep; 132(9):876-80. PubMed ID: 685905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.